Literature DB >> 28638968

[Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].

P M Villiger1.   

Abstract

According to the Chapel Hill Classification, large vessel vasculitides encompass giant cell arteritis (GCA) and the histologically related Takakaysu arteritis (TAK). The two diseases lack autoantibodies and present with a systemic inflammatory response. GCA typically shows a sudden onset with profound sickness, loss of appetite and of body weight, and temporal headache. Due to the substantial risk of sudden blindness, diagnostic work-up has to be performed immediately and treatment started without delay. A close association between polymyalgia rheumatica (PMR) and GCA is well established. Takayasu arteritis very often begins in adolescence. In contrast to GCA, the general symptoms are much less pronounced and aside from occasional carotidodynia there is a lack of diagnostic symptoms. TAK is often diagnosed in late stages due to exercise-induced claudication.

Entities:  

Keywords:  Claudication; Inflammation; Polymyalgia rheumatica; Takayasu arteritis; Temporal arteritis, Horton

Mesh:

Year:  2017        PMID: 28638968     DOI: 10.1007/s00393-017-0331-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  30 in total

Review 1.  Role of ultrasound in the understanding and management of vasculitis.

Authors:  Wolfgang A Schmidt
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

2.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  Ustekinumab for the treatment of refractory giant cell arteritis.

Authors:  Richard Conway; Lorraine O'Neill; Eileen O'Flynn; Phil Gallagher; Geraldine M McCarthy; Conor C Murphy; Douglas J Veale; Ursula Fearon; Eamonn S Molloy
Journal:  Ann Rheum Dis       Date:  2016-05-03       Impact factor: 19.103

4.  A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.

Authors:  Carol A Langford; David Cuthbertson; Steven R Ytterberg; Nader Khalidi; Paul A Monach; Simon Carette; Philip Seo; Larry W Moreland; Michael Weisman; Curry L Koening; Antoine G Sreih; Robert Spiera; Carol A McAlear; Kenneth J Warrington; Christian Pagnoux; Kathleen McKinnon; Lindsy J Forbess; Gary S Hoffman; Renée Borchin; Jeffrey P Krischer; Peter A Merkel
Journal:  Arthritis Rheumatol       Date:  2017-03-08       Impact factor: 10.995

5.  A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

Authors:  R F Spiera; H J Mitnick; M Kupersmith; M Richmond; H Spiera; M G Peterson; S A Paget
Journal:  Clin Exp Rheumatol       Date:  2001 Sep-Oct       Impact factor: 4.473

6.  Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

Authors:  Gary S Hoffman; Maria C Cid; Karen E Rendt-Zagar; Peter A Merkel; Cornelia M Weyand; John H Stone; Carlo Salvarani; Weichun Xu; Sudha Visvanathan; Mahboob U Rahman
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

7.  Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Peter M Villiger; Sabine Adler; Stefan Kuchen; Felix Wermelinger; Diana Dan; Veronika Fiege; Lukas Bütikofer; Michael Seitz; Stephan Reichenbach
Journal:  Lancet       Date:  2016-03-04       Impact factor: 79.321

8.  Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.

Authors:  M De Silva; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

9.  Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial.

Authors:  Thorsten Klink; Julia Geiger; Marcus Both; Thomas Ness; Sonja Heinzelmann; Matthias Reinhard; Konstanze Holl-Ulrich; Dirk Duwendag; Peter Vaith; Thorsten Alexander Bley
Journal:  Radiology       Date:  2014-08-06       Impact factor: 11.105

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  1 in total

Review 1.  Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm.

Authors:  Sayantan Jana; Mei Hu; Mengcheng Shen; Zamaneh Kassiri
Journal:  Exp Mol Med       Date:  2019-12-19       Impact factor: 8.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.